EA202092239A1 - MCL-1 INHIBITORS - Google Patents

MCL-1 INHIBITORS

Info

Publication number
EA202092239A1
EA202092239A1 EA202092239A EA202092239A EA202092239A1 EA 202092239 A1 EA202092239 A1 EA 202092239A1 EA 202092239 A EA202092239 A EA 202092239A EA 202092239 A EA202092239 A EA 202092239A EA 202092239 A1 EA202092239 A1 EA 202092239A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mcl
inhibitors
compounds
methods
pharmaceutical compositions
Prior art date
Application number
EA202092239A
Other languages
Russian (ru)
Inventor
Хан Чу
Хуан А. Герреро
Анна И. Хёртли
Тхэ Х. Хван
Лань Цзян
Дэррил Като
Тецуя Кобаяши
Джон Э. Нокс
Скотт И. Лазервит
Сяофэнь Ли
Дэвид В. Линь
Джонатан В. Медли
Майкл Л. Митчелл
Деван Надутхамби
Закари Ньюби
Нил Х. Сквайерс
Викки Х. Цуй
Чандрасекар Венкатарамани
Уильям Дж. Уоткинс
Хун Ян
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Priority claimed from PCT/US2019/032053 external-priority patent/WO2019222112A1/en
Publication of EA202092239A1 publication Critical patent/EA202092239A1/en

Links

Abstract

Настоящее изобретение в целом относится к соединениям и фармацевтическим композициям, подходящим для применения в способах лечения рака.The present invention generally relates to compounds and pharmaceutical compositions suitable for use in methods of treating cancer.

EA202092239A 2018-10-24 2019-05-13 MCL-1 INHIBITORS EA202092239A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862749918P 2018-10-24 2018-10-24
PCT/US2019/032053 WO2019222112A1 (en) 2018-05-14 2019-05-13 Mcl-1 inhibitors

Publications (1)

Publication Number Publication Date
EA202092239A1 true EA202092239A1 (en) 2021-04-26

Family

ID=75817399

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092239A EA202092239A1 (en) 2018-10-24 2019-05-13 MCL-1 INHIBITORS

Country Status (1)

Country Link
EA (1) EA202092239A1 (en)

Similar Documents

Publication Publication Date Title
EA202092590A1 (en) PYRIDAZINONES AS PARP7 INHIBITORS
ZA202007007B (en) Mcl-1 inhibitors
EA201792231A1 (en) INDOLAMIN-2,3-DIOXYGENASE INHIBITORS AND METHODS OF THEIR APPLICATION
EA201790078A1 (en) MNK INHIBITORS AND RELATED METHODS
EA201692079A1 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1
EA201691134A1 (en) NEW GLUTAMINASE INHIBITORS
EA201690027A1 (en) IDO INHIBITORS
EA201690306A1 (en) IDO INHIBITORS
EA201591599A1 (en) IDO INHIBITORS
EA201591823A1 (en) IDO INHIBITORS
EA201690152A1 (en) IDO INHIBITORS
EA201592068A1 (en) INHANSER INHIBITORS ZESTE HOMOLOGIST 2
EA201692480A1 (en) PHARMACEUTICAL COMPOSITION
EA201692268A1 (en) PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS
EA201992137A1 (en) Pyrimidopyrimidinones as Wee-1 Kinase Inhibitors
EA201692470A1 (en) PHARMACEUTICAL COMBINATIONS
EA201792580A1 (en) IDO INHIBITORS
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
EA201890364A1 (en) COMPOUNDS SUITABLE FOR INHIBITING ROR-GAMMA-t
EA201791933A1 (en) INHIBITION OF OLIG2 ACTIVITY
EA201990508A1 (en) ACTIVITY INHIBITION Olig2
EA201790604A1 (en) Inhibitors of histonedehylase
EA202092239A1 (en) MCL-1 INHIBITORS
EA202190125A1 (en) PYRIDOPYRIMIDINONE DERIVATIVES FOR USE AS Axl INHIBITORS
EA201990041A1 (en) COMPOSITIONS CONTAINING THYMOL, AND THEIR APPLICATION FOR THE TREATMENT OF ROSACEA FOR LOCAL APPLICATION